EE200100199A - Kateetrilpõhineva revaskularisatsiooni ennetamisevõi edasilükkamise meetod - Google Patents

Kateetrilpõhineva revaskularisatsiooni ennetamisevõi edasilükkamise meetod

Info

Publication number: EE200100199A
Authority: EE; Estonia
Prior art keywords: preventing; based revascularization; delaying; catheter; delaying catheter
Prior art date: 1998-09-30

Application number

EEP200100199A

Other languages

English (en)

Estonian (et)

Inventor

Michael Black Donald

Original Assignee

Warner-Lambert Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-30

Filing date

1999-07-08

Publication date

2002-06-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22289955&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200100199(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-07-08 Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company

2002-06-17 Publication of EE200100199A publication Critical patent/EE200100199A/xx

Links

230000000250 revascularization Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Materials For Medical Uses (AREA)
Surgical Instruments (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Media Introduction/Drainage Providing Device (AREA)

EEP200100199A 1998-09-30 1999-07-08 Kateetrilpõhineva revaskularisatsiooni ennetamisevõi edasilükkamise meetod EE200100199A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10245798P	1998-09-30	1998-09-30
PCT/US1999/015385 WO2000018395A1 (en)	1998-09-30	1999-07-08	Method for preventing or delaying catheter-based revascularization

Publications (1)

Publication Number	Publication Date
EE200100199A true EE200100199A (et)	2002-06-17

Family

ID=22289955

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200100199A EE200100199A (et)	1998-09-30	1999-07-08	Kateetrilpõhineva revaskularisatsiooni ennetamisevõi edasilükkamise meetod

Country Status (35)

Country	Link
US (1)	US20080119561A1 (xx)
EP (1)	EP1117392B1 (xx)
JP (1)	JP2002525321A (xx)
KR (1)	KR20010079955A (xx)
CN (1)	CN1197565C (xx)
AP (1)	AP1708A (xx)
AT (1)	ATE260100T1 (xx)
AU (1)	AU768474B2 (xx)
BG (1)	BG105471A (xx)
BR (1)	BR9914098A (xx)
CA (1)	CA2343299C (xx)
CZ (1)	CZ20011035A3 (xx)
DE (1)	DE69915084T2 (xx)
DK (1)	DK1117392T3 (xx)
EA (1)	EA007427B1 (xx)
EE (1)	EE200100199A (xx)
ES (1)	ES2214872T3 (xx)
HK (1)	HK1042436A1 (xx)
HR (1)	HRP20010236A2 (xx)
HU (1)	HUP0103648A3 (xx)
ID (1)	ID30255A (xx)
IL (2)	IL141953A0 (xx)
IS (1)	IS5889A (xx)
NO (1)	NO20011615L (xx)
NZ (1)	NZ510500A (xx)
OA (1)	OA11787A (xx)
PL (1)	PL346980A1 (xx)
PT (1)	PT1117392E (xx)
SI (1)	SI1117392T1 (xx)
SK (1)	SK4122001A3 (xx)
TR (1)	TR200100901T2 (xx)
UA (1)	UA73292C2 (xx)
WO (1)	WO2000018395A1 (xx)
YU (1)	YU23901A (xx)
ZA (1)	ZA200102230B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2246894T3 (es)	1999-08-30	2006-03-01	Sanofi-Aventis Deutschland Gmbh	Ramipril para la prevencion de sucesos cardiovasculares.
AU2001256278A1 (en) *	2000-04-18	2001-10-30	Bayer Aktiengesellschaft	Use of cse inhibitors for treating heart failure
EP1303266A1 (en) *	2000-07-14	2003-04-23	Warner-Lambert Company	Treatment of eating disorders using carboxyalkylethers
US6982251B2 (en)	2000-12-20	2006-01-03	Schering Corporation	Substituted 2-azetidinones useful as hypocholesterolemic agents
CA2563051A1 (en)	2001-01-26	2002-08-01	Schering Corporation	Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
IL156422A0 (en)	2001-01-26	2004-01-04	Schering Corp	The use of substituted azetidinone compounds for the treatment of sitosterolemia
US7071181B2 (en)	2001-01-26	2006-07-04	Schering Corporation	Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
US7053080B2 (en)	2001-09-21	2006-05-30	Schering Corporation	Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7056906B2 (en)	2001-09-21	2006-06-06	Schering Corporation	Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
ATE345793T1 (de)	2001-09-21	2006-12-15	Schering Corp	Behandlung von xanthom mittels azetidinon- derivate als hemmer der sterol absorption
WO2004043456A1 (en)	2002-11-06	2004-05-27	Schering Corporation	Cholesterol absorption inhibitors for the treatment of demyelination
JP2006519869A (ja)	2003-03-07	2006-08-31	シェーリング　コーポレイション	置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用
ES2318274T3 (es)	2003-03-07	2009-05-01	Schering Corporation	Compuestos de azetidinona sustituida, formulaciones y uso de los mismos para el tratamiento de hipercolesterolemia.
ATE406364T1 (de)	2003-03-07	2008-09-15	Schering Corp	Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5157025A (en) *	1991-04-01	1992-10-20	E. R. Squibb & Sons, Inc.	Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
US5807388A (en) *	1994-05-25	1998-09-15	The Trustees Of Columbia University In The City Of New York	Myocardial revascularization through the endocardial surface using a laser
AU1095695A (en) *	1993-11-09	1995-05-29	Brigham And Women's Hospital	Hmg-coa reductase inhibitors in the normalization of vascular endothelial dysfunction
US5545628A (en) *	1995-01-10	1996-08-13	Galephar P.R. Inc.	Pharmaceutical composition containing fenofibrate
US5648387A (en) *	1995-03-24	1997-07-15	Warner-Lambert Company	Carboxyalkylethers, formulations, and treatment of vascular diseases
RO120816B1 (ro) *	1995-11-02	2006-08-30	Warner-Lambert Company	COMPOZIŢIE FARMACEUTICĂ PE BAZĂ DE INHIBITOR DE ACIL-CoA COLESTEROL O-ACIL-TRANSFERAZEI ŞI INHIBITOR AL REDUCTAZEI HMG-CoA şi UTILIZAREA ACESTEIA
SE506272C2 (sv) *	1996-03-18	1997-11-24	Paul Edholm	Förfarande och anordning för att bestämma bildläge och bildvinkel i en röntgenbild
IL117702A0 (en) *	1996-03-28	1996-07-23	Tel Aviv Medical Center Resear	Drug for hyperlipoproteinemia
WO1998001116A1 (en) *	1996-07-09	1998-01-15	Merck & Co., Inc.	Therapy for combined hyperlipidemia
US5861399A (en) *	1996-07-17	1999-01-19	Heart Care Partners	Methods and compositions for the rapid and enduring relief of inadequate myocardial function
US6180660B1 (en) *	1997-08-26	2001-01-30	Merck & Co., Inc.	Cholesterol-lowering therapy
NZ503982A (en) *	1997-12-12	2002-03-28	Warner Lambert Co	Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

1999
- 1999-07-08 AU AU49750/99A patent/AU768474B2/en not_active Ceased
- 1999-07-08 EA EA200100370A patent/EA007427B1/ru not_active IP Right Cessation
- 1999-07-08 NZ NZ510500A patent/NZ510500A/xx unknown
- 1999-07-08 ID IDW20010902A patent/ID30255A/id unknown
- 1999-07-08 SK SK412-2001A patent/SK4122001A3/sk unknown
- 1999-07-08 ES ES99933763T patent/ES2214872T3/es not_active Expired - Lifetime
- 1999-07-08 OA OA1200100080A patent/OA11787A/en unknown
- 1999-07-08 PL PL99346980A patent/PL346980A1/xx not_active Application Discontinuation
- 1999-07-08 YU YU23901A patent/YU23901A/sh unknown
- 1999-07-08 PT PT99933763T patent/PT1117392E/pt unknown
- 1999-07-08 CN CNB998116297A patent/CN1197565C/zh not_active Expired - Fee Related
- 1999-07-08 KR KR1020017004021A patent/KR20010079955A/ko not_active Ceased
- 1999-07-08 DE DE69915084T patent/DE69915084T2/de not_active Revoked
- 1999-07-08 EP EP99933763A patent/EP1117392B1/en not_active Revoked
- 1999-07-08 TR TR2001/00901T patent/TR200100901T2/xx unknown
- 1999-07-08 CZ CZ20011035A patent/CZ20011035A3/cs unknown
- 1999-07-08 AT AT99933763T patent/ATE260100T1/de not_active IP Right Cessation
- 1999-07-08 HU HU0103648A patent/HUP0103648A3/hu unknown
- 1999-07-08 JP JP2000571914A patent/JP2002525321A/ja active Pending
- 1999-07-08 BR BR9914098-5A patent/BR9914098A/pt not_active Application Discontinuation
- 1999-07-08 DK DK99933763T patent/DK1117392T3/da active
- 1999-07-08 CA CA002343299A patent/CA2343299C/en not_active Expired - Fee Related
- 1999-07-08 SI SI9930535T patent/SI1117392T1/xx unknown
- 1999-07-08 AP APAP/P/2001/002112A patent/AP1708A/en active
- 1999-07-08 IL IL14195399A patent/IL141953A0/xx active IP Right Grant
- 1999-07-08 EE EEP200100199A patent/EE200100199A/xx unknown
- 1999-07-08 WO PCT/US1999/015385 patent/WO2000018395A1/en not_active Application Discontinuation
- 1999-08-07 UA UA2001042933A patent/UA73292C2/uk unknown
2001
- 2001-03-12 IL IL141953A patent/IL141953A/en not_active IP Right Cessation
- 2001-03-14 IS IS5889A patent/IS5889A/is unknown
- 2001-03-16 ZA ZA200102230A patent/ZA200102230B/en unknown
- 2001-03-29 HR HR20010236A patent/HRP20010236A2/hr not_active Application Discontinuation
- 2001-03-29 NO NO20011615A patent/NO20011615L/no not_active Application Discontinuation
- 2001-04-25 BG BG105471A patent/BG105471A/xx unknown
2002
- 2002-05-31 HK HK02104071A patent/HK1042436A1/xx not_active IP Right Cessation
2007
- 2007-11-28 US US11/946,217 patent/US20080119561A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2002525321A (ja)	2002-08-13
EP1117392B1 (en)	2004-02-25
ATE260100T1 (de)	2004-03-15
CN1342072A (zh)	2002-03-27
IL141953A (en)	2006-07-05
US20080119561A1 (en)	2008-05-22
SI1117392T1 (en)	2004-06-30
EA007427B1 (ru)	2006-10-27
ES2214872T3 (es)	2004-09-16
DE69915084D1 (de)	2004-04-01
PT1117392E (pt)	2004-07-30
AU768474B2 (en)	2003-12-11
DK1117392T3 (da)	2004-06-14
CA2343299A1 (en)	2000-04-06
BG105471A (en)	2001-12-31
AP2001002112A0 (en)	2001-06-30
UA73292C2 (en)	2005-07-15
PL346980A1 (en)	2002-03-11
EP1117392A1 (en)	2001-07-25
CN1197565C (zh)	2005-04-20
AU4975099A (en)	2000-04-17
DE69915084T2 (de)	2004-07-22
IL141953A0 (en)	2002-03-10
SK4122001A3 (en)	2002-06-04
IS5889A (is)	2001-03-14
OA11787A (en)	2005-07-26
ZA200102230B (en)	2002-06-18
BR9914098A (pt)	2001-07-31
YU23901A (sh)	2003-07-07
EA200100370A1 (ru)	2001-10-22
NZ510500A (en)	2003-10-31
CA2343299C (en)	2008-04-01
WO2000018395A1 (en)	2000-04-06
KR20010079955A (ko)	2001-08-22
AP1708A (en)	2007-01-10
NO20011615D0 (no)	2001-03-29
TR200100901T2 (tr)	2001-08-21
HUP0103648A2 (hu)	2003-08-28
HUP0103648A3 (en)	2003-10-28
HRP20010236A2 (en)	2002-04-30
HK1042436A1 (en)	2002-08-16
NO20011615L (no)	2001-04-24
ID30255A (id)	2001-11-15
CZ20011035A3 (cs)	2001-10-17

Publication	Publication Date	Title
FI981491L (fi)	1999-12-30	Tukiaseman konfigurointimenetelmä
DE69938817D1 (de)	2008-07-10	Erstellungsverfahren
DE69831091D1 (de)	2005-09-08	System zur transmyokardialen revaskularisation
DE69916360D1 (de)	2004-05-19	Flügelprofil
NO990187D0 (no)	1999-01-15	Benzosulfon-derivater
EE200100199A (et)	2002-06-17	Kateetrilpõhineva revaskularisatsiooni ennetamisevõi edasilükkamise meetod
DE69912949D1 (de)	2003-12-24	Entwässerungsverfahren
FI980517L (fi)	1999-09-07	Kanavanvaihtomenetelmä
ATE252547T1 (de)	2003-11-15	Matrixmetalloproteinaseinhibitoren
NO984867D0 (no)	1998-10-16	Lineariseringsteknikk
NO20010085D0 (no)	2001-01-05	Angiogeneseinhibitorer
DE69928197D1 (de)	2005-12-15	Atzverfahren
FI981486L (fi)	1999-12-27	Kanavanvaihtomenetelmä
EP1025851A4 (en)	2001-07-04	alpha-GLUCOSIDASE HEMMER
DE59909139D1 (de)	2004-05-19	Rollenwickler
FI991128L (fi)	1999-11-20	Päällystysmenetelmä
ATE266631T1 (de)	2004-05-15	Imidamid-derivate
ID29194A (id)	2001-08-09	Metode untuk menguapkan aminonitril
DE69930852D1 (de)	2006-05-24	Prenyltransferase-inhibitoren
FI981293A0 (fi)	1998-06-05	Menetelmä kuivauksen tehostamiseksi
NO980306D0 (no)	1998-01-23	Fremgangsmåte for applisering av skje
FI980095A7 (fi)	1999-07-20	Laivan rakentamismenetelmä
FI981448A0 (fi)	1998-06-24	Parannettu paperinvalmistusmenetelmä
FI981207A0 (fi)	1998-05-29	Demodulaatiomenetelmä
DK37398A (da)	1998-03-18	Fremstillingsmetode